Decoding Supplement Labels
"Natural," "Clean," and "Supports" Explained
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
This is a product-literacy entry about settled regulatory facts, not a clinical efficacy claim, so it is graded on how well documented those facts are rather than on trial evidence for a health benefit. The core points are strongly supported. That structure/function claims ('supports immunity,' 'promotes focus') need no FDA pre-market approval, rest on the manufacturer's own substantiation, and must carry the verbatim disclaimer 'This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease' is codified in 21 CFR 101.93 and FDA's structure/function-claims guidance. The disease-claim versus structure/function line is defined in the same regulation. That advertising, as opposed to labeling, is the FTC's domain and requires 'competent and reliable scientific evidence,' generally randomized human clinical trials, is set out in the FTC's 2022 Health Products Compliance Guidance. The enforcement actions are completed and matter-of-record: in 2010 the FTC settled with Nestle HealthCare Nutrition over BOOST Kid Essentials, a children's drink whose ads claimed it would prevent upper respiratory infections, protect against colds and flu by strengthening immunity, and cut daycare and school absences, the agency's first case challenging probiotic advertising, with a final order in January 2011; in 2008 the makers of Airborne settled FTC deceptive-advertising charges over unsupported cold-prevention and germ-fighting claims, part of a $30 million total resolution. FDA's 'natural' policy is informal and undefined by rule. The grade 4 (not 5) reflects that the 'health halo' component rests on consumer-perception research rather than regulation, and enforcement is illustrative rather than exhaustive.
- FDA
- Structure/function claims need no FDA pre-approval; "natural" is largely undefined
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
The core risk is misplaced confidence: parents may read disease prevention or proven efficacy into carefully worded 'support' claims, undefined 'natural/clean' labels, and impressive-sounding 'clinically proven' or 'doctor recommended' language that legally promise very little. Because the health halo operates even when no claim is made, skepticism has to be active rather than reactive. Documented FTC actions against children's-supplement marketers show the gap between label language and real substantiation is not hypothetical. None of this means every claim is false; some products are well formulated. But the wording on a label is not itself evidence of benefit. The practical move is to ignore the adjectives, read the actual nutrients and doses, look for independent third-party testing, and verify any health-relevant claim against a primary source. Supplements are not a substitute for medical evaluation: any decision about whether a child needs a supplement, and any concern about a specific health condition, should be directed to the child's pediatrician or a qualified healthcare provider rather than settled by a product label.
The language on a children's supplement is engineered to reassure, and reading it is its own skill. Most label phrases, 'supports immunity,' 'promotes focus,' 'supports digestive health,' are structure/function claims permitted under the 1994 Dietary Supplement Health and Education Act (DSHEA): they need no FDA pre-market approval, only a manufacturer's own file of substantiation, and they must carry the small-print disclaimer that the statement 'has not been evaluated by the Food and Drug Administration' and the product is 'not intended to diagnose, treat, cure, or prevent any disease.' Disease claims (that a product prevents, treats, or cures an illness) are a different, far stricter category and are generally not allowed on a supplement. Advertising is separately policed by the Federal Trade Commission, which requires 'competent and reliable scientific evidence,' generally randomized human trials, behind health benefit claims, and has taken documented action against children's supplement marketers for 'clinically proven' and 'scientifically proven' claims they could not support. Words like 'natural,' 'clean,' and 'pure' have no formal FDA definition for supplements. And consumer research shows a health halo operates even when a label makes no health claim at all, so skepticism has to be active.
"Supports immunity," "clean," "natural," "doctor-formulated", the words on a kids' supplement are mostly marketing, and the rules behind them are looser than they sound.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
What people get wrong
Often said'Supports immunity' on a label means the product is proven to boost immunity.
Actually'Supports...' is a structure/function claim permitted under DSHEA. It needs no FDA pre-market approval, rests only on the manufacturer's own substantiation file, and legally must carry the disclaimer that it is 'not evaluated by the FDA' and 'not intended to diagnose, treat, cure, or prevent any disease.' It signals a marketing-permissible phrase, not demonstrated efficacy (21 CFR 101.93).
Often said'Natural,' 'clean,' and 'pure' guarantee a safer or better supplement.
ActuallyFDA has never issued a formal rule defining 'natural,' and 'clean' and 'pure' have no regulatory definition at all. FDA's informal longstanding policy treats 'natural' only as nothing artificial or synthetic added, and expressly does not address processing methods or nutritional benefit. These are marketing words, not assurances of safety, purity, or effectiveness; the ingredient list, the doses, and third-party testing tell you far more (FDA, Use of the Term Natural on Food Labeling).
Often said'Clinically proven' or 'doctor recommended' on a supplement means it works, verified by real science.
ActuallyThese are 'establishment claims,' and the FTC requires the advertiser to actually hold the level of proof stated: 'clinically proven' requires competent and reliable scientific evidence, generally randomized human trials on the finished product, and '#1 doctor recommended' requires a random, statistically representative survey of relevant doctors. The FTC has sued children's-supplement makers whose 'clinically proven' or 'scientifically proven' claims rested on a tiny company-run study or on nothing at all (FTC Health Products Compliance Guidance; FTC v. TruHeight; FTC v. NourishLife).
Often saidIf a label makes no health claim, you won't be misled.
ActuallyConsumer research on the 'health halo' shows people infer benefits a label never promised: a favorable cue on the package raises perceived healthfulness of unmentioned attributes, and shoppers attribute benefits to labeled products even when no benefit is claimed. The persuasion happens whether or not anything is promised, so active skepticism, not just claim-reading, is the defense (health-halo studies, Health Communication / PMC).
Who profits, and who pushes back
Consumer-perception study
People struggled to distinguish vetted disease claims from unregulated structure/function claims, and 54% believed a product would cut heart-attack risk even when its label made no such claim, the health halo operating on its own.
FDA claim framework
Structure/function claims require no FDA pre-approval, only a manufacturer evidence file and a disclaimer that the statement is not FDA-evaluated and the product is not intended to diagnose, treat, cure, or prevent disease.
Third-party-verification advocates
Because supplements are not FDA pre-market tested and label adjectives are largely undefined, independent testing is the meaningful signal that contents match the label.
Supplement marketing
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Leans on "natural," "clean," "doctor-formulated," and "supports" language and a reassuring health halo to drive sales, wording that promises little under the rules, with a clear commercial interest.
Where the research comes from
Most of the published research on this comes from one place. 54% of it is from Believed benefit even with NO claim. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Believed benefit even with NO claim | 54% |
Research published from: Global.
How we got here
Modern US supplement label language descends from the 1994 Dietary Supplement Health and Education Act (DSHEA), which set supplements apart from drugs and let manufacturers make structure/function claims without pre-market FDA proof, provided they hold substantiation and print the disclaimer; FDA codified the disclaimer and the disease versus structure/function line in 21 CFR 101.93 in 2000. Advertising, as opposed to labeling, has long been the Federal Trade Commission's domain: the FTC's 1998 Dietary Supplements Advertising Guide set the 'competent and reliable scientific evidence' bar, replaced in December 2022 by the broader Health Products Compliance Guidance. The FTC's enforcement against child and immune claims is concrete, from the 2008 Airborne cold-prevention settlement to the 2010 BOOST Kid Essentials action, the agency's first probiotic case, finalized in January 2011. FDA opened a public process in 2015 to define 'natural' but has never finished it, so the term remains governed only by informal policy.
Modern US supplement label language is a product of the 1994 Dietary Supplement Health and Education Act (DSHEA), which set supplements apart from drugs: manufacturers may make structure/function claims without pre-market FDA proof, provided they hold substantiation and print the 'not evaluated by the FDA' disclaimer, while disease claims stay under stricter drug-style review. FDA codified the disclaimer and the disease/structure line in 21 CFR 101.93. Advertising, as opposed to labeling, has long been the Federal Trade Commission's domain; the FTC's Dietary Supplements Advertising Guide (1998) and its successor Health Products Compliance Guidance (2022) set the 'competent and reliable scientific evidence' bar. Across the 2000s and 2010s, 'support,' 'natural,' and 'clean' language spread across the aisle, the FTC brought repeated actions against children's-vitamin and children's-supplement marketers, and FDA opened, but never finished, a public process to define 'natural.' Consumer researchers meanwhile documented the health halo, the tendency to infer benefits a label never promised, making label literacy a core modern parenting skill.
- 1994DSHEA establishes the structure/function claim framework and the mandatory 'not evaluated by the FDA' disclaimer, separating supplements from drugs
- 1998FTC issues 'Dietary Supplements: An Advertising Guide for Industry,' formalizing the 'competent and reliable scientific evidence' substantiation standard
- 2010FTC settles with NBTY, NatureSmart, and Rexall Sundown over Disney- and Marvel Heroes-themed children's vitamins; $2.1M in refunds for deceptive DHA and brain/eye-development claims
- 2015FTC settles with NourishLife over 'Speak' children's speech supplements marketed as 'scientifically proven'; $200,000 and endorsement-disclosure requirements
- 2016FDA opens a public comment process on defining 'natural' for food labeling; as of this writing no formal rule has issued
- 2022FTC replaces its supplement guide with the broader 'Health Products Compliance Guidance,' reaffirming that health benefit claims generally require randomized human trials
- 2025-2026FTC action against Vanilla Chip LLC (TruHeight) over children's height supplements advertised 'clinically proven' on a 32-subject company study and thousands of fabricated reviews; consent order and multimillion-dollar judgment
At a glance
- "Natural"
- Not meaningfully FDA-defined for supplements
- "Supports..."
- A structure/function claim; no FDA pre-approval
- Disclaimer
- "...not evaluated by the FDA..."
- Believed a benefit with no claim at all
- 54% (study)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Decoding Supplement Labels. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
Structure/function claims ('supports immunity') need no FDA pre-market approval, require only manufacturer substitution and a notification within 30 days, and must not be disease claims.
The required verbatim disclaimer is 'This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease,' in boldface no smaller than one-sixteenth inch; the section also defines the disease versus structure/function line.
eCFR, 21 CFR 101.93 (Certain types of statements for dietary supplements)
A disease claim (treats, prevents, cures, or mitigates a disease) converts a supplement into a drug requiring FDA approval; nutrient-deficiency diseases such as scurvy are excluded from the disease definition.
The FTC requires 'competent and reliable scientific evidence,' generally randomized controlled human clinical trials, for health benefit claims, and holds advertisers to the level of proof an 'establishment claim' states; issued December 20, 2022, replacing the 1998 Advertising Guide.
In 2010 the FTC settled with Nestle HealthCare Nutrition over BOOST Kid Essentials, which advertised that it prevents upper respiratory infections in children, protects against colds and flu by strengthening immunity, and reduces daycare and school absences; the agency's first case challenging probiotic advertising, requiring FDA approval or two well-designed clinical studies for future claims.
FTC press release, Nestle Subsidiary to Settle FTC False Advertising Charges (BOOST Kid Essentials)
The FTC approved the final order settling the BOOST Kid Essentials charges in January 2011.
FTC press release, FTC Approves Final Order (Nestle / BOOST Kid Essentials)
In 2008 the makers of Airborne settled FTC deceptive-advertising charges that there was no competent and reliable scientific evidence for its cold-prevention, germ-fighting, and reduced-severity claims; total settlement funds reached $30 million.
FTC press release, Makers of Airborne Settle FTC Charges of Deceptive Advertising
FDA has never issued a rule defining 'natural'; its informal longstanding policy treats it only as nothing artificial or synthetic added, expressly does not address production or processing methods, and does not consider nutritional or health benefit.
FDA opened a public comment process in 2015 to consider defining 'natural' for food labeling but has not completed rulemaking.
Federal Register, Use of the Term 'Natural' in the Labeling of Human Food Products
The 2008 Airborne resolution, combining the FTC settlement with a related private class action, brought the total refund fund to $30 million; independent coverage of the deceptive cold-remedy claims.
Quackwatch, Makers of Airborne Settle FTC Charges of Deceptive Advertising